| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Veterinary Pathology, Vol 20, Issue 2 127-142, Copyright © 1983 by American College of Veterinary Pathologists
ARTICLES |
S. R. Gilbertson, I. D. Kurzman, R. E. Zachrau, A. I. Hurvitz and M. M. Black
We studied 232 dogs that underwent mastectomy for mammary epithelial neoplasms. The mastectomy specimens were evaluated according to structural parameters found to be prognostically significant in human mammary neoplasms, such as grade of atypia in non-invasive proliferations of duct epithelium, extent of malignant disease, and nuclear differentiation in malignant neoplasms. In this study, the biologic behavior of mammary lesions was assessed according to the frequency of development of de novo or recurrent invasive carcinoma within two years. Our data indicate that we can recognize structural variables which permit classification of mammary neoplasms into categories with distinct patterns of biologic behavior. In addition to normotypic proliferative lesions and invasive malignant neoplasms, we were able to identify precancerous atypic and non-invasive malignant neoplasms that are considered precursor lesions in women. Also, as in women, nuclear differentiation was found to be a prognostically significant variable. Lymphoid cellular reactions, considered to be structural correlates of host-tumor immune responses in women, were noted in 35% of dogs with precancerous or malignant neoplasms. Application of the described parameters should facilitate comparative studies of canine and human mammary carcinogenesis and use of the dog as a model for the development of new therapeutic modalities and immunoprophylaxis of human mammary cancer.
This article has been cited by other articles:
![]() |
E. Antuofermo, M. A. Miller, S. Pirino, J. Xie, S. Badve, and S. I. Mohammed Spontaneous Mammary Intraepithelial Lesions in Dogs A Model of Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2247 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brunelle, E. A. Sartin, L. G. Wolfe, J. Sirois, and M. Dore Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines. Vet. Pathol., September 1, 2006; 43(5): 656 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brunetti, G. Sarli, R. Preziosi, I. Monari, and C. Benazzi E-Cadherin and {beta}-catenin Reduction Influence Invasion but not Proliferation and Survival in Canine Malignant Mammary Tumors Vet. Pathol., November 1, 2005; 42(6): 781 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin de las Mulas, Y. Millan, and R. Dios A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor {alpha}and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the Dog Vet. Pathol., February 1, 2005; 42(2): 200 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dore, I. Lanthier, and J. Sirois Cyclooxygenase-2 Expression in Canine Mammary Tumors Vet. Pathol., March 1, 2003; 40(2): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |